Glen Hughes

Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies

Marie C. South, A. Nyström, Neil Henderson, 2016, PloS one.

Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker.

Dave Singh, A. Platt, M. Fidock, 2021, PloS one.

Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours

C. Harbron, D. Hodgson, A. Lau, 2013, Virchows Archiv.

Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies.

M. Fidock, S. Eketjäll, E. Michaëlsson, 2017, Journal of immunological methods.

Point of care measurement of eosinophil derived neurotoxin (EDN) as a biomarker of eosinophilic asthma

A. Platt, T. Dwyer, M. Olsson, 2017 .

BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides

S. Haeberlein, S. Eketjäll, K. Matsuguma, 2017, Journal of clinical pharmacology.